EUROPEAN UROLOGY SUPPLEMENTS, vol.8, no.5, pp.439-447, 2009 (SCI-Expanded)
Context: High-risk localised prostate cancer (PCa) is defined as significant likelihood of death from PCa or development of distant metastases. It is important to identify patients at high risk of progression who may benefit from neoadjuvant or adjuvant therapies.